Saitama, Japan

Mitsuo Ohashi

This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Seiyaku Kabushiki Kaisha. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuo Ohashi. Retrieved from https://idiyas.com/inventor/mitsuo-ohashi-ueq9l9ll

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mitsuo Ohashi

Introduction

Mitsuo Ohashi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents that address cognitive impairments.

Latest Patents

Ohashi holds a patent for an ameliorating agent for dysmnesia. This innovative agent comprises effective components, including pyrazolo[1,5-a]pyridine derivatives. The general formula for these derivatives includes various configurations of hydrogen and lower alkyl groups, showcasing his expertise in medicinal chemistry.

Career Highlights

Ohashi is associated with Kyorin Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has focused on developing solutions for cognitive disorders, reflecting his commitment to improving mental health.

Collaborations

Ohashi has collaborated with esteemed colleagues, including Fukutaro Taga and Takashi Hirayama. Their combined efforts have contributed to advancements in the pharmaceutical industry.

Conclusion

Mitsuo Ohashi's innovative work in developing an ameliorating agent for dysmnesia highlights his significant role in the field of pharmaceuticals. His contributions continue to impact the understanding and treatment of cognitive impairments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…